Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.

OVERLAP
41%
OVERLAP
BY WEIGHT
15
# OF OVERLAPPING
HOLDINGS
FTXH
49
HOLDINGS
31%
ALSO IN IHE
IHE
36
HOLDINGS
43%
ALSO IN FTXH
SECTOR DRIFT (FTXH minus IHE)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in FTXH |
Weight in IHE |
Overlap | |
---|---|---|---|---|
JOHNSON & JOHNSON | 8.0% | 24.5% | 8.0% | |
MERCK & CO. INC. | 6.7% | 4.4% | 4.4% | |
PFIZER INC | 6.7% | 4.2% | 4.2% | |
VIATRIS, INC. | 4.0% | 4.7% | 4.0% | |
BRISTOL-MYERS SQUIBB CO | 5.8% | 3.9% | 3.9% |
FTXH Overweight Relative to IHE
ABBVIE INC | 7.8% | |
UNITED THERAPEUTICS CORP | 4.7% | |
BIOGEN IDEC INC | 3.8% | |
GILEAD SCIENCES INC | 3.7% | |
AMGEN INC | 3.3% | |
REGENERON PHARMACEUTICALS | 3.0% | |
MEDPACE HOLDINGS, INC. | 2.8% | |
PFIZER INC | 2.6% | |
MERCK & CO. INC. | 2.3% | |
EXELIXIS INC | 2.0% |
FTXH Underweight Relative to IHE
ELI LILLY & CO | -16.9% | |
JOHNSON & JOHNSON | -16.5% | |
ROYALTY PHARMA PLC CLASS A | -4.6% | |
CORCEPT THERAPEUTICS INC | -2.6% | |
AXSOME THERAPEUTICS, INC. | -1.8% | |
LIGAND PHARMACEUTICALS-CL B | -1.5% | |
ELANCO ANIMAL HEALTH, INC. | -1.5% | |
SUPERNUS PHARMACEUTICALS INC | -1.2% | |
PRESTIGE BRANDS HOLDINGS INC | -0.9% | |
TARSUS PHARMACEUTICALS, INC. | -0.9% |